Aster Capital Management DIFC Ltd Has $1.29 Million Position in Stryker Corporation $SYK

Aster Capital Management DIFC Ltd cut its stake in shares of Stryker Corporation (NYSE:SYK) by 44.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,491 shares of the medical technology company’s stock after selling 2,779 shares during the quarter. Stryker makes up about 0.7% of Aster Capital Management DIFC Ltd’s portfolio, making the stock its 28th largest position. Aster Capital Management DIFC Ltd’s holdings in Stryker were worth $1,291,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Clayton Financial Group LLC acquired a new stake in shares of Stryker in the 3rd quarter valued at about $26,000. Elevation Point Wealth Partners LLC bought a new position in Stryker in the second quarter worth approximately $28,000. Kilter Group LLC acquired a new stake in Stryker in the second quarter valued at approximately $29,000. Howard Hughes Medical Institute bought a new stake in shares of Stryker during the second quarter valued at approximately $29,000. Finally, ANTIPODES PARTNERS Ltd acquired a new position in shares of Stryker during the third quarter worth approximately $34,000. 77.09% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

SYK has been the subject of a number of recent research reports. Robert W. Baird set a $437.00 price target on shares of Stryker in a research note on Friday, January 30th. Truist Financial decreased their target price on shares of Stryker from $400.00 to $392.00 and set a “hold” rating for the company in a research report on Thursday, December 18th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Stryker in a research report on Monday, December 22nd. Wells Fargo & Company lifted their price target on Stryker from $452.00 to $456.00 and gave the company an “overweight” rating in a research note on Friday, November 14th. Finally, Wall Street Zen raised Stryker from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Thirteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $426.47.

Insider Buying and Selling

In other news, Director Ronda E. Stryker sold 250,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the sale, the director owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. The trade was a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 5.90% of the stock is currently owned by company insiders.

Stryker Stock Up 0.5%

Stryker stock opened at $386.04 on Friday. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $147.73 billion, a P/E ratio of 45.96, a P/E/G ratio of 2.24 and a beta of 0.87. The firm has a 50 day moving average price of $362.53 and a 200-day moving average price of $369.14. Stryker Corporation has a twelve month low of $329.16 and a twelve month high of $404.87.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating the consensus estimate of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The business had revenue of $7.17 billion for the quarter, compared to the consensus estimate of $7.12 billion. During the same quarter in the prior year, the business earned $4.01 earnings per share. Stryker’s revenue for the quarter was up 11.4% on a year-over-year basis. As a group, equities analysts predict that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be paid a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, March 31st. Stryker’s payout ratio is currently 41.90%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.